Company news
TrivarX Limited news in 2017
TrivarX Limited's news releases, calls and decks from 2017, newest first.
Medibio & Mayo Clinic collaborate on depression technology
December 13, 2017
Appendix 4C - quarterly
October 30, 2017
MEB completes heavily oversubscribed institutional placement
October 12, 2017
Response to ASX Query
October 10, 2017
Medibio enters into an Agreement with Otsuka Pharmaceutical
October 8, 2017
Medibio enters agreement with Mayo Clinc
October 3, 2017
Medibio initiates confirmatory study
August 21, 2017
Medibio announces positive clinical study results
August 2, 2017
Quarterly ASX Update and Cashflows
July 27, 2017
Scientific breakthrough on objective diagnosis of PTSD
June 26, 2017
Independent researchers present first data validating MEB
June 8, 2017
Signed second agreement for Wellness
May 17, 2017
MEB Signs Strategic Joint Development Agreement with Mayo Cl
May 10, 2017
Quarterly ASX Update and Cashflow
April 27, 2017
MEB enters fully funded Paediatric mental illness diagnostic
April 10, 2017
Conversion of Options to Partly Paid shares
April 5, 2017
MEB appoints US med-tech veteran as CEO & Managing Director
February 16, 2017
Early Redemption of Convertible Note
January 30, 2017
Partnership with leading US University on PTSD
January 24, 2017